Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) EBIT Margin: 2010-2018

Historic EBIT Margin for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -2,788.89%.

  • EyePoint Pharmaceuticals' EBIT Margin fell 122889.00% to -2,788.89% in Q3 2018 from the same period last year, while for Sep 2018 it was -1,517.36%, marking a year-over-year decrease of 128987.00%. This contributed to the annual value of -887.34% for FY2018, which is 64094.00% down from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its EBIT Margin stood at -2,788.89% for Q3 2018, which was down 103.85% from -1,368.11% recorded in Q2 2018.
  • EyePoint Pharmaceuticals' 5-year EBIT Margin high stood at 82.15% for Q3 2014, and its period low was -5,808.00% during Q4 2017.
  • Over the past 3 years, EyePoint Pharmaceuticals' median EBIT Margin value was -1,560.00% (recorded in 2017), while the average stood at -1,824.66%.
  • The largest annual percentage gain for EyePoint Pharmaceuticals' EBIT Margin in the last 5 years was 124,836bps (2017), contrasted with its biggest fall of 580,643bps (2017).
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' EBIT Margin stood at -790.02% in 2014, then tumbled by 20,580bps to -995.82% in 2015, then surged by 99,424bps to -1.57% in 2016, then slumped by 580,643bps to -5,808.00% in 2017, then tumbled by 122,889bps to -2,788.89% in 2018.
  • Its EBIT Margin was -2,788.89% in Q3 2018, compared to -1,368.11% in Q2 2018 and -504.09% in Q1 2018.